{"title": "hotez", "author": null, "url": "https://www.bcm.edu/people-search/peter-hotez-23229", "hostname": "bcm.edu", "description": "BCM", "sitename": "Baylor College of Medicine", "date": "2023-01-01", "cleaned_text": "Peter Jay Hotez, M.D., Ph.D. Picture Peter Jay Hotez, M.D., Ph.D. Dean for the National School of Tropical Medicine Phone Phone [hotez@bcm.edu](mailto:hotez@bcm.edu) Positions - Dean for the National School of Tropical Medicine - Baylor College of Medicine Houston, United States - Professor - Departments of Pediatrics and Molecular Virology & Microbiology Baylor College of Medicine Houston, Texas United States - Endowed Chair in Tropical Pediatrics - Texas Children's Hospital Houston, Texas United States - Co-Director - Texas Children's Hospital Center for Vaccine Development Houston, Texas United States - Founding Editor in Chief - PLOS Neglected Tropical Diseases - University Professor - Baylor University Houston, Texas United States - Fellow in Disease and Poverty - James A. Baker III Institute for Public Policy Rice University Houston, Texas United States - Health Policy Scholar - Center for Medical Ethics and Health Policy Baylor College of Medicine - Faculty-Senior Fellow - Hagler Institute for Advanced Study & Scowcroft Institute of Intl Affairs Texas A&M University Education - M.D. from Weill Cornell Medical College - 05/1987 - New York, NY United States - Ph.D. from The Rockefeller University - 05/1986 - New York, NY United States - B.A. (magna cum laude) from Yale University - 05/1980 - New Haven, Connecticut United States Professional Interests - Drug and Vaccine Delivery - Tropical Medicine Websites Projects - Coronavirus Vaccines - - Development of coronavirus vaccines including vaccines administered to over 100 million people in India and Indonesia. Ongoing work includes research on a multivalent pan-coronavirus vaccine to protect against multiple coronavirus variants. - Human Hookworm Vaccine - - Development of a vaccine for the more than 400 million people suffering from hookworm infection in the world today. Vaccine currently in phase 1 clinical trials in Brazil and Gabon. - Schistosomiasis Vaccine - - Schistosomiasis afflicts over 200 million people around the globe and is the deadliest disease among the seven most prevalent NTDs, killing an estimated 280,000 people annually. Our vaccine is entering phase 1 clinical trials. - Chagas Disease and Leishmaniasis Vaccine - - A project for the selection and discovery of antigens appropriate to advance into the development process of new vaccines to combat Chagas disease (American trypanosomiasis) and leishmaniasis. - SARS Vaccine - - A new vaccine to prevent severe acute respiratory syndrome (SARS). A prototype RBD219 N1 vaccine is entering scale-up process development - Multivalent Anthelmintic Vaccine Discovery - - A panhelmintic (roundworm) and trichuris (whipworm), soil-transmitted helminths afflicting of people around the world. [Log In](https://signature.bcm.edu/login) to edit your profile "}